Showing results (521-530 of 548) with videos related to
Sort By:
Pageof 55
The Journal of Infectious Diseases|March 27, 2024
A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US AdultsCarol M Kao, Christina A Rostad, Lauren E Nolan, et al.The Journal of Allergy and Clinical Immunology|August 25, 2019
Common variable immunodeficiency-associated endotoxemia promotes early commitment to the T follicular lineageCarole Le Coz, Bertram Bengsch, Caroline Khanna, et al.Gastroenterology|September 30, 2010
Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopesArthur Y Kim, Thomas Kuntzen, Joerg Timm, et al.Hepatology (Baltimore, Md.)|June 15, 2007
Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolutionJoerg Timm, Bin Li, Marcus G Daniels, et al.Blood|May 4, 2007
Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non-genotype 1 infectionJulian Schulze Zur Wiesch, Georg M Lauer, Joerg Timm, et al.Journal of Medicinal Chemistry|January 23, 2018
Identification of a Novel Positron Emission Tomography (PET) Ligand for Imaging β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE-1) in BrainLei Zhang, Laigao Chen, Jason K Dutra, et al.The Journal of Burn Care & Rehabilitation|March 8, 2002
A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth centuryT L Palmieri, D G Greenhalgh, J R Saffle, et al.The Journal of Allergy and Clinical Immunology|June 24, 2018
Patients with common variable immunodeficiency with autoimmune cytopenias exhibit hyperplastic yet inefficient germinal center responsesNeil Romberg, Carole Le Coz, Salomé Glauzy, et al.Journal of Virology|December 28, 2007
High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcomeVictoria Kasprowicz, Julian Schulze Zur Wiesch, Thomas Kuntzen, et al.The Journal of Pharmacology and Experimental Therapeutics|April 6, 2010
Pharmacodynamics and pharmacokinetics of the gamma-secretase inhibitor PF-3084014Thomas A Lanz, Kathleen M Wood, Karl E G Richter, et al.Pageof 55